The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global e-prescribing market is expected to exhibit a CAGR of 22.3% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
E-prescribing, or electronic prescribing, refers to a web or cloud-based solution that enables healthcare providers to generate digital prescriptions. It is a computer-based process for generating and transmitting accurate prescription orders to a hospital-based or standalone pharmacy. E-prescription software can automatically refill prescriptions for patients and manage medications according to their history and integrate them with an electronic medical record (EMR) system. In comparison to the traditionally used manual prescriptions, it offers various benefits, such as improved patient safety and healthcare quality, minimal risks of medication errors and loss of handwritten prescriptions and enhanced convenience for doctors and physicians.
Rapid digitization in the healthcare industry and the widespread adoption of electronic health records (EHRs), represent as the key factors driving the growth of the market. As the coronavirus disease (COVID-19) pandemic continues to spread across the globe, there has been a significant increase in the demand for telemedicine and telehealth solutions for providing specialized care to patients. Furthermore, the increasing focus of authorities on minimizing the abuse of controlled substances and the unauthorized distribution of pharmaceutical drugs is stimulating the market growth. E-prescription software can aid in identifying duplicate or fraudulent entries in prescriptions, thereby limiting pharmaceutical malpractices. Additionally, various technological advancements, such as the development of solutions with higher performance capabilities and ease of deployment, are acting as other growth-inducing factors. These systems improve organizational workflow and enhance patient compliance by providing cost-effective generic formulations. Other factors, including the implementation of favorable government policies to improve public health and extensive improvements in the healthcare infrastructure, are anticipated to drive the market further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global e-prescribing market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on component, delivery mode, end user and specialties.
Breakup by Component:
Breakup by Delivery Mode:
Breakup by End User:
Breakup by Specialties:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being Allscripts Healthcare Solutions Inc., Athenahealth Inc. (Veritas Capital and Evergreen Coast Capital), Cerner Corporation, Computer Programs and Systems Inc., DrFirst.com Inc., Epic Systems Corporation, Henry Schein Inc., Medical Information Technology Inc., Nextgen Healthcare Inc. and Surescripts LLC.
|Base Year of the Analysis||2021|
|Segment Coverage||Component, Delivery Mode, End User, Specialties, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Allscripts Healthcare Solutions Inc., Athenahealth Inc. (Veritas Capital and Evergreen Coast Capital), Cerner Corporation, Computer Programs and Systems Inc., DrFirst.com Inc., Epic Systems Corporation, Henry Schein Inc., Medical Information Technology Inc., Nextgen Healthcare Inc. and Surescripts LLC|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
We expect the global e-prescribing market to exhibit a CAGR of 22.3% during 2022-2027.
The growing adoption of e-prescription software to automatically refill prescriptions for patients and
manage medications based on their recorded history, along with identifying fraudulent entries, is
primarily driving the global e-prescribing market.
The sudden outbreak of the COVID-19 pandemic has led to the rising demand for cloud-based solution
across the healthcare sector, such as telemedicine and telehealth solutions, as they facilitate e-
prescription for providing specialized care to the patients.
Based on the component, the global e-prescribing market has been segmented into solutions and
services. Currently, solutions hold the majority of the total market share.
Based on the delivery mode, the global e-prescribing market can be divided into web-based, cloud-
based, and on-premises, where web-based currently exhibits a clear dominance in the market.
Based on the end user, the global e-prescribing market has been categorized into hospitals, pharmacies,
office-based physicians, and others. Among these, hospitals account for the majority of the global
Based on the specialties, the global e-prescribing market can be segregated into oncology, sports
medicine, neurology, cardiology, and others. Currently, oncology holds the largest market share.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global e-prescribing market include Allscripts Healthcare Solutions Inc.,
Athenahealth Inc. (Veritas Capital and Evergreen Coast Capital), Cerner Corporation, Computer
Programs and Systems Inc., DrFirst.com Inc., Epic Systems Corporation, Henry Schein Inc., Medical
Information Technology Inc., Nextgen Healthcare Inc., and Surescripts LLC.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at